On September 20, 2025
Meet us at the iQMedix medical congress
Dear Colleagues,
Our iQMedix Medical Congress will take place on 20.09.2025. We are very pleased to inform you about our exciting program.
- Access to the latest research results
- Direct exchange with colleagues
- Networking Networking with other specialist disciplines
- Comprehensive information on personalized tumor diagnostics
Please register.
Be our guest, we look forward to seeing you!
Participation, coffee breaks and lunch are free of charge.
iQMedix DOCTOR CONGRESS
An informative day with unique speakers
We are very pleased to announce our exciting program. Please be patient, details about the program, speakers and topics will be published soon.
-
Use of integrative medicine in the treatment of breast diseases - from meditation to individualized medicine
Dr. med. Jens-Paul Seldte, Medical Director of Bietigheim Clinic, specialist in gynaecology and obstetrics -
Integrative personalized tumour therapy in everyday practice
Dr. med. Anwar Giryes, Medical Director of the Swiss Medical Clinic, Zurich -
Tumors, tumor therapy and their development over time
Dr. rer. nat. Reiner Hubert Steffan, Managing Director and Senior Scientist -
iQMedix - Personalized tumour diagnostics through gene expression analysis
Reinhard Becker, MD, Managing Director of iQMedix -
The metabolism of the tumor cell and the fasting-mimicking diet
Reinhard Becker, MD, Managing Director of iQMedix -
Ferroptosis by Vit-C high dose - How to eliminate resistant tumor cells by ferroptosis-
Dr. Ing. Bernd Becker, Managing Director iQMedix -
Autonomy training - hope for cancer patients - What is the scientific and evidence-based basis for autonomy training, how does it intervene in the bio-psycho-social system and what does it look like in practice?
Dr. phil. Bojan Godina, social behavioral scientist and autonomy trainer
Log in
Be our guest,
participation is free of charge
We look forward to your registration.
Participation is free of charge, coffee breaks & lunch included.
Venue
on September 20, 2025
from 09.30 - 17.00
QMedix GmbH
Cubex One
Franz-Volhard-Str. 5
D-68167 Mannheim
Germany
Our current article
From resistance mechanism to targeted therapy:
How molecular biology analysis is transforming cancer treatment
We are at a turning point in oncology. The traditional approach of “one-size-fits-all” therapy according to guidelines is increasingly giving way to a personalized approach that relies on an in-depth understanding of individual tumour biology. This revolution in cancer therapy is largely driven by groundbreaking advances in molecular biology diagnostics.
Get an outlook on future developments in preventive resistance control and learn more about
- the challenge of therapy resistance in cancer,
- the paradigm shift through Liquid Biopsy,
- the way in which molecular signatures are decoded and
- the process of personalized therapy development.